Seeking Single Cells Secrets
The National Institutes of Health has awarded grants totaling $7.9 million in 2014 to 25 research teams who are unraveling the workings of single cells, as part of an effort to spur development of personalized treatments that target disease at the cellular level. The grants are supported by the NIH Common Fund’s Single Cell Analysis Program (SCAP).
“Cells are the most basic form of life; they make up every tissue and organ system in our bodies,” said James Anderson, director of NIH’s Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI). “Most cells are healthy, but this can change. They can become cancerous, get infected by viruses, undergo cycles and ageing. With these awards, we are making an investment that holds promise for widespread advances across medicine.”
This year’s SCAP grants fund applications submitted in response to requests for applications issued last December.
One group of projects is validating and refining already established technologies for studying the biological properties of single cells:
• Modeling how tissue properties of cells emerge during development
• Detecting genetic changes in live animals
• Manipulating cells with submicron precision
• Tracking fat metabolism using millisecond technology
• Detecting the tiniest genetic variation
• Discovering how cells renew themselves and differentiate as they develop
• Profiling gene expression in a cell’s nucleus to identify early protein signatures
• Optimizing “disease-in-a-dish” analysis
One group of grants is pioneering exceptionally innovative new technologies:
• A genetic imaging tool to label vast numbers of cell lineages
• Microsecond spectroscopy to repetitively assess a single cell in a living organism
• A high definition cell “printer” based on precise fluid mechanics, robotics and microscopy
• Optically guided technology to identify cell types that give rise to different tissues
• Light-induced cellular gene changes in a live vertebrate animal
• Gene expression sensors that report out changes among cells in living tissue
• Real-time, micro-level scans tracking a transplanted cell in a live mouse
• Spectrometry so sensitive that even subcellular components can be chemically analyzed
And one group of grants adds a single cell component to already active projects:
• How a key immune cell can be either an acute defender or a memory cell
• How a mouth bacterium can cause minor irritation or aggressive periodontal disease
• Tracking environmentally triggered changes in a gene in a formative human cell
• Characterizing how micro-level gene expression changes in a cancer cell suppress tumors
• How a gene regulator exerts effects on different classes of target genes
• Genetic mechanisms by which intestinal lining cells are regenerated
• Targeted genetic alteration of a key cellular process by which genes are switched off
• Characterizing the workings of immune cells that target leukemia
• Genetics of a disease-in-a-dish disease model derived from a type of heart cell.
For a detailed description of all funded SCAP grants, click here.
Related News
-
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
News Amgen sues Samsung biologics unit over biosimilar for bone disease
Samsung Bioepis, the biologics unit of Samsung, has been issued a lawsuit brought forth by Amgen over proposed biosimilars of Amgen’s bone drugs Prolia and Xgeva. -
News CPHI Podcast Series: Why we need to consider women in clinical trials
The latest episode of the CPHI Podcast Series with Lucy Chard covers women's health, specifically women's representation in clinical trials, the associated bias, and the impacts on health for this population. -
News US FDA does not approve MDMA therapy for PTSD, requests more data
The MDMA-based therapeutic developed by Lykos Therapeutics, a California-based Public Benefit Corporation (PBC), has been reviewed and unapproved by the US FDA. The regulator has requested additional phase III trial data for further safety and efficacy... -
News Novartis and Viatris latest facing lawsuit over HeLa cell misuse
Global pharmaceutical companies Novartis and Viatris are the latest hit with a lawsuit claim pertaining to alleged misuse of the ‘HeLa’ cell line from the estate of woman whose cancerous tissue cells were taken without consent. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production. -
News Novel oral Type 1 diabetes drug gains US FDA IND designation
A University of Alabama at Birmingham startup has gained FDA clearance for Investigational New Drug clinical trials for an oral Type 1 diabetes drug, a milestone for diabetes treatment. -
News A Day in the Life of a Vice President in R&D & Engineering
In the Day in the Life of Series, we've already had the chance to get to know a range of people in various roles in the pharma industry. In the latest interview we get a glimpse into the R&D side of things from Jennifer Sorrells, Vice Presiden...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance